Enhancing Representativeness in Clinical Trials

This chapter examines the growing involvement of the industry in cardiovascular clinical trials amid decreasing federal funding. It emphasizes the need for diversity and inclusiveness in trial populations to improve outcomes and discusses best practices and accountability in trial design and community engagement.